IL10 and colitis: Additionally, Bifidobacterium has been reported to alleviate DSS-induced colitis by suppressing the IL-17A response and prevent intestinal inflammation through the induction of intestinal IL-10-producing Tr1 cells, further confirming the protective role of Bifidobacterium in colitis [82, 83].